Literature DB >> 2820071

Treatment of stage I lung cancer (T1N0M0, T2N0M0).

D W Moores, M F McKneally.   

Abstract

Patients with stage I lung cancer can be offered surgical treatment with an excellent prognosis for recovery and long-term cure. The recent revision of the staging definition has rearranged the prognostic categories, further improving the prognosis in Stage I disease by eliminating patients with a higher risk of recurrence. The most vexing issues remaining are the infrequency of diagnosis of lung cancer at this stage and the increasing incidence of lung cancer of all stages, even among nonsmokers. Economical screening, abolition of cigarette smoking, control of airborne environmental carcinogens, and the continued search for effective systemic treatment remain challenges for the future.

Entities:  

Mesh:

Year:  1987        PMID: 2820071     DOI: 10.1016/s0039-6109(16)44331-8

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  2 in total

1.  Mediastinoscopy as a predictor of resectability in patients with bronchogenic carcinoma.

Authors:  D S Ríordáin; D J Buckley; T Aherne
Journal:  Ir J Med Sci       Date:  1991-09       Impact factor: 1.568

2.  The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC).

Authors:  K Karrer; H Denck; H Karnicka-Mlodkowska; P Drings; J Orel; G M Salzer; M Thermann; A Lattuneddu; Y Sun; E Hata
Journal:  Med Oncol Tumor Pharmacother       Date:  1989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.